Stock Research for XXII

XXII

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

XXII Stock Chart & Research Data

The XXII chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the XXII chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


XXII Due diligence Resources & Stock Charts

The XXII stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View XXII Detailed Price Forecast - CNN Money CNN View XXII Detailed Summary - Google Finance
Yahoo View XXII Detailed Summary - Yahoo! Finance Zacks View XXII Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View XXII Trends & Analysis - Trade-Ideas Barrons View XXII Major Holders - Barrons
NASDAQ View XXII Call Transcripts - NASDAQ Seeking View XXII Breaking News & Analysis - Seeking Alpha
Spotlight View XXII Annual Report - CompanySpotlight.com OTC Report View XXII OTC Short Report - OTCShortReport.com
TradeKing View XXII Fundamentals - TradeKing Charts View XXII SEC Filings - Bar Chart
WSJ View Historical Prices for XXII - The WSJ Morningstar View Performance/Total Return for XXII - Morningstar
MarketWatch View the Analyst Estimates for XXII - MarketWatch CNBC View the Earnings History for XXII - CNBC
StockMarketWatch View the XXII Earnings - StockMarketWatch MacroAxis View XXII Buy or Sell Recommendations - MacroAxis
Bullish View the XXII Bullish Patterns - American Bulls Short Pains View XXII Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View XXII Stock Mentions - StockTwits PennyStocks View XXII Stock Mentions - PennyStockTweets
Twitter View XXII Stock Mentions - Twitter Invest Hub View XXII Investment Forum News - Investor Hub
Yahoo View XXII Stock Mentions - Yahoo! Message Board Seeking Alpha View XXII Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for XXII - SECform4.com Insider Cow View Insider Transactions for XXII - Insider Cow
CNBC View XXII Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for XXII - OTC Markets
Yahoo View Insider Transactions for XXII - Yahoo! Finance NASDAQ View Institutional Holdings for XXII - NASDAQ


Stock Charts

FinViz View XXII Stock Insight & Charts - FinViz.com StockCharts View XXII Investment Charts - StockCharts.com
BarChart View XXII Stock Overview & Charts - BarChart Trading View View XXII User Generated Charts - Trading View




Latest Financial News for XXII


Investors Who Bought 22nd Century Group (NYSEMKT:XXII) Shares Three Years Ago Are Now Up 120%
Posted on Friday April 19, 2019

22nd Century Group, Inc. (NYSEMKT:XXII) shareholders might be concerned after seeing the share price drop 21% in the last quarter. But that doesn't undermine the rather lovely longer-term return, if you measure over the l...


Grossly Misleading “Short and Distort” Article Wrongfully Attempts to Dupe 22nd Century Group Shareholders
Posted on Thursday April 18, 2019

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a world leader in tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/cannabis research, today commented on a grossly misleading article published yesterday by an anonymous self-professed short seller of the Company’s stock. Publishing under the pen name “Fuzzy Panda,” the author – who will not even identify who he is – continued his baseless smear campaign against the Company in an effort to depress the share price of 22nd Century stock and to make a personal profit by duping shareholders into selling their shares. Although 22nd Century does not normally respond to “short and distort” articles or to “hit pieces,” the Company believes the grossly misleading mischaracterizations and wrongful innuendo contained in the subject article warranted a Company response.


22nd Century Group Hires Former Imperial Brands Head of Regulatory Science
Posted on Wednesday April 17, 2019

22nd Century Group, Inc. (NYSE American:XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/cannabis research, announced today the hiring of John D. Pritchard as Vice President of Regulatory Science. Mr. Pritchard was formerly the Head of Regulatory Science for Imperial Brands, U.K. (LSE:IMB).


Cannabis Stocks to Watch
Posted on Thursday April 11, 2019

HENDERSON NV / ACCESSWIRE / April 11, 2019 / With the market off to its best first quarter over the past 2 decades and the cannabis industry being one of the hottest in the market, now is an ideal time ...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.